In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective α1A receptor antagonists for the treatment of benign prostatic hyperplasia
…, KL Glass, KE Rittle, KF Gilbert, TG Steele…
文献索引：Steele, Thomas G.; Coburn, Craig A.; Patane, Michael A.; Bock, Mark G. Tetrahedron Letters, 1998 , vol. 39, # 51 p. 9315 - 9318
α1 Adrenergic receptors mediate both vascular and lower urinary tract tone, and α1 receptor antagonists such as terazosin (1b) are used to treat both hypertension and benign prostatic hyperplasia (BPH). Recently, three different subtypes of this receptor have been identified,
